Align Technology, Inc. $ALGN Shares Purchased by Farther Finance Advisors LLC

Farther Finance Advisors LLC increased its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 42.2% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 310 shares of the medical equipment provider’s stock after purchasing an additional 92 shares during the quarter. Farther Finance Advisors LLC’s holdings in Align Technology were worth $59,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Teacher Retirement System of Texas acquired a new stake in shares of Align Technology during the first quarter worth about $1,647,000. Asset Management One Co. Ltd. lifted its holdings in shares of Align Technology by 14.5% during the first quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after purchasing an additional 4,009 shares during the period. Czech National Bank lifted its holdings in shares of Align Technology by 3.3% during the second quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after purchasing an additional 537 shares during the period. Acadian Asset Management LLC acquired a new stake in shares of Align Technology during the first quarter worth about $20,194,000. Finally, Parallel Advisors LLC lifted its holdings in shares of Align Technology by 66.0% during the second quarter. Parallel Advisors LLC now owns 1,044 shares of the medical equipment provider’s stock worth $198,000 after purchasing an additional 415 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Piper Sandler decreased their target price on Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a report on Thursday, July 31st. Morgan Stanley reissued an “equal weight” rating and issued a $154.00 price target (down from $249.00) on shares of Align Technology in a report on Thursday, July 31st. Weiss Ratings reissued a “hold (c-)” rating on shares of Align Technology in a report on Saturday, September 27th. Evercore ISI boosted their price target on Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Wednesday, July 9th. Finally, Zacks Research raised Align Technology from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 30th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $215.00.

Align Technology Stock Up 2.7%

NASDAQ ALGN opened at $132.17 on Monday. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $246.19. The business’s fifty day simple moving average is $140.20 and its 200-day simple moving average is $165.69. The firm has a market cap of $9.58 billion, a PE ratio of 22.29, a P/E/G ratio of 1.49 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter in the prior year, the firm earned $2.41 EPS. The firm’s revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. Research analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology declared that its board has approved a stock repurchase program on Tuesday, August 5th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to buy up to 2% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

Insider Activity at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of Align Technology stock in a transaction dated Friday, August 1st. The shares were acquired at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the acquisition, the chief executive officer directly owned 184,945 shares in the company, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.66% of the stock is currently owned by corporate insiders.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.